810222C

C6-NBD Glucosyl Ceramide

Avanti Research^™ - A Croda Brand 810222C

• 别名: N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-glucosyl-β1-1′-sphingosine
• 经验公式（希尔记法）: C₃₆H₅₉N₅O₁₁
• CAS号: 94885-03-7
• 分子量: 737.88
• MDL號碼: MFCD00063542
• 分類程式碼代碼: 12352211
• NACRES: NA.25

属性

• 化驗: >99% (TLC)
• 形狀: liquid
• 包裝: pkg of 1 × 1 mL (810222C-250ug); pkg of 1 × 1 mg (81022C-1MG)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 810222C
• 濃度: 0.25 mg/mL (810222C-250ug)
• 運輸包裝: dry ice
• 儲存溫度: −20°C

说明

一般說明

C6-NBD Glucosyl Ceramide is a fluorescent derivative of biologically active compound, glucosyl ceramide. Glucosyl ceramide belongs to the class of sphingolipids that are synthesized in the cis/medial-Golgi apparatus by the glycosylation of ceramide.

應用

C6-NBD Glucosyl Ceramide may be used as a substrate for glucocerebrosidase (GCase) activity assay in Drosophila melanogaster and mice.

生化／生理作用

Glucosylceramide is the precursor of different glycosphingolipids including gangliosides and sulfatides. Glucosyl ceramide is also known to be responsible for axon growth of neural cells. The accumulation of glucosyl ceramide is associated with an inherited lysosomal storage disorder, Gaucher′s disease.

包裝

5 mL Amber Glass Screw Cap Vial (81022C-1MG)

5 mL Clear Glass Sealed Ampule (810222C-250ug)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全信息

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H302,H315,H319,H331,H336,H351,H361d,H372
• 防範說明: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 標靶器官: Central nervous system
• 水污染物質分類（WGK）: WGK 3